MGUS progression and excess weight
During the six months or so that I've been reading and occasionally contributing to these conversations, I've seen numerous threads relating to slowing MGUS progression by means of various diets or supplements. Although there are a few ongoing clinical trials, the evidence for those things is equivocal. For one factor, however, the evidence is strong: excess weight, especially following MGUS diagnosis, increases the likelihood of progression to MM. I was diagnosed with high-risk MGUS about ten months ago, and am teetering on the treatment / no treatment edge, so this is of considerable interest. Reference:
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830028
Interested in more discussions like this? Go to the Blood Cancers & Disorders Support Group.
Reading these threads always provides greater awareness of the science and studies that are currently ongoing. So much data that the only way to keep up is to read it here. I have never heard that BMI could influence MAGUS to MM. This is great info to know. Thanks
Excess weight increases the risk of a number of different cancers. Is your MAGUS the same as MGUS or is it a variant?
There may be clinical trials for high-risk MGUS, and more likely if someone has bone lesions, kidney disease, or other manifestations, but in general MGUS is a wait-and-see condition. I have had IgA Kappa MGUS for 8 years and some risk (1q21 gain) of progression, but my kappa and other numbers ramp up and down. I do take about 3 gm of bioavailable curcumin a day, just in case that has any effect on TNF (tumor necrosis factor), diet, enough sleep, exercise, destress, and try to have fun. One of the reasons that MGUS is wait and see is that the meds and BMT can have some side effects, and it may not progress to MM.
What is MAGUS?
> What is MAGUS?
SORCEROR. Medically, I don't know. MGUS?
There are definitely clinical trials, both ongoing and recruiting, concerning various aspects of MGUS. See https://clinicaltrials.gov/search?cond=MGUS Particularly interesting for me is an ongoing trial of the efficacy of daratumumab in delaying progression of high-risk MGUS and SMM. https://clinicaltrials.gov/study/NCT03236428 However, that study is only Phase II, meaning that even if it finds delay in progression, it does not show ultimate benefit.
Regarding MAGUS, a person on this string of comments has posted a few times about "MAGUS" and I was curious as to whether this is something different than MGUS. Perhaps a spell check issue.
@kayabbott I assumed it was a spellcheck issue. I'm happy to have spellcheck assist me if my fat fingers produce a typo, but I don't like it when it changes my intended words.
I am fluent in typo.